Lupus patient organizations are working to launch the World Lupus Federation (WLF), a new coalition aiming to improve life for the more than five million lupus patients worldwide. The WLF will facilitate the efforts of some 200 national groups to promote lupus education, awareness, and advocacy. New members of the WLF’s International Steering Committee are…
May is Lupus Awareness Month, and the Lupus Foundation of America has started a Know Lupus campaign to increase public understanding of the disease and to raise research money so that a future with “no lupus” might be possible. Almost two-thirds of U.S. population knows little or nothing about lupus, a…
A California lawmaker, Sen. John Moorlach, has led a successful effort to designate May as California Lupus Awareness Month. The state’s Senate approved the resolution with a resounding 36-0 vote — cheered on by California’s three lupus organziations, the Lupus Foundation of Northern California, the Lupus Foundation of Southern California, and…
TxCell SA and Ospedale San Raffaele (OSR) announced the launch of a strategic research and development collaboration that will include efforts to treat  lupus nephritis, one of the most severe complications of lupus, using TxCell’s proprietary Chimeric-Antigen-Receptor engineered regulatory T (CAR-Treg) cells, an immunotherapy. Under the agreement, TxCell and OSR will conduct preclinical pharmacology and toxicology…
French company NEOVACS announced that its Investigational New Drug (IND) application for IFNα Kinoid in lupus, now in Phase 2b development, was approved by the South Korean Health Authority. NEOVACS was established in 1993. Today, the biotech is a leader in active immunotherapy technology platforms (Kinoids) for autoimmune and/or inflammatory diseases. NEOVACS…
QuesGen Systems, a provider of research services to organizations and scientists working on brain health and treatments for traumatic brain injury (TBI), is expanding its business and has announced the establishment of a new business relationship with ImmunArray, a private diagnostics company with headquarters in Rehovot, Israel, and…
Three organizations focused on helping patients with lupus are banding together once again to recognize an outstanding research project. The Alliance for Lupus Research, the Lupus Foundation of America, and the Lupus Research Institute are calling for research nominations to win the Lupus Insight…
The American Autoimmune Related Diseases Association (AARDA) is celebrating its 25th anniversary this month with the inauguration of its yearlong Autoimmune Heroes campaign that names actresses Kellie Martin (@kelliemartin) and Haley Ramm (@halesbells), along with her mother Barbara Ramm (@BarbeeVintage), as the first #AutoimmuneHeroes for their help in raising public awareness and promoting…
The Lupus Foundation of America has announced two new staff appointments: Susan Manzi, M.D., MPH, the chief adviser of clinical development and the Lupus Foundation’s new medical director; and Oklahoma Medical Research Foundation member Joan T. Merrill, M.D., who will serve as chief adviser for clinical development. Manzi is chair…
ImmuPharma PLC announced that Phase 3 clinical studies evaluating the safety and efficacy of Lupuzor — its lead compound to treat lupus – are now getting underway and enrolling patients in Europe, and continuing to enroll people in the U.S., where first dosing has already begun. The pivotal trial, titled “A 52-Week,…